Comments

Novo Nordisk Stock Price, Quotes and Forecasts

Q: What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

NVONYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$89.47

-0.08-0.09%

Pre-Market: 4:41 AM EDT

Novo Nordisk (NVO) Forecast

News Earnings Novo Nordisk (NVO) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Novo Nordisk Stock Price, Quotes and Forecasts | NYSE:NVO | Benzinga

Explore Novo Nordisk stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NVO.

Open	-
Close	-
Volume / Avg.	21.36K / 8.66M
Day Range	- - -
52 Wk Range	77.82 - 148.15
Market Cap	$397.16B
P/E Ratio	28.22
Dividend Yield	1.80%
Exchange	NYSE
RSI	54
Short Interest	0.43%
Days to Cover	1.3

Recent News

6 Stocks to Buy as European Markets Soar

Benzinga Research Team

Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision

A lawsuit challenges the FDA's decision to remove semaglutide from the shortage list, alleging it was arbitrary and harms patients who rely on compounded versions of the drug.

Vandana Singh

Trump Reportedly Warns Big Pharma: Move Manufacturing To US Or Face Tariffs

President Donald Trump has issued a stringent warning to pharmaceutical companies, advising them to repatriate their manufacturing to the US or face the possibility of tariffs.

Namrata Sen

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	21.36K / 8.66M
Day Range	- - -
52 Wk Range	77.82 - 148.15
Market Cap	$397.16B
P/E Ratio	28.22
Dividend Yield	1.80%
Exchange	NYSE
RSI	54
Short Interest	0.43%
Days to Cover	1.3

About Novo Nordisk

Sector

Health Care

Industry

Pharmaceuticals

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Novo Nordisk (NVO) stock?

You can purchase shares of Novo Nordisk (NYSE:NVO) through any online brokerage.

View our list of the best stock brokerages

Who are Novo Nordisk (NVO) competitors?

Other companies in Novo Nordisk’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA), Novartis (NYSE:NVS) and Haleon (NYSE:HLN).

What is the forecast, or price target, for Novo Nordisk (NVO) stock?

Novo Nordisk has a consensus price target of $116.57.

What is the current price for Novo Nordisk (NVO)?

The stock price for Novo Nordisk (NYSE: NVO) is $89.47 last updated February 27, 2025 at 4:41 AM EST.

Does Novo Nordisk (NVO) pay a dividend?

A quarterly cash dividend of 2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 2, 2012 to stockholders of record on March 22, 2012.

When is Novo Nordisk (NYSE:NVO) reporting earnings?

Novo Nordisk’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Novo Nordisk (NVO) going to split?

There is no upcoming split for Novo Nordisk.

What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.